--2025/Q1-- / 193.428M--
--2024/Q4-- / 191.926M--
Nov 5, 20242024/Q3196.830M / 199.824M--
Aug 1, 20242024/Q2199.685M / 191.306M--
May 7, 20242024/Q1172.325M / 164.259M--
US Stock MarketDetailed Quotes
APLS Apellis Pharmaceuticals
- 28.915
- -0.075-0.26%
Trading Nov 20 12:43 ET
3.60BMarket Cap-14243P/E (TTM)
28.950High27.380Low1.47MVolume28.780Open28.990Pre Close41.61MTurnover1.75%Turnover RatioLossP/E (Static)124.39MShares73.80052wk High15.17P/B2.44BFloat Cap24.34052wk Low--Dividend TTM84.36MShs Float94.750Historical High--Div YieldTTM5.42%Amplitude11.450Historical Low28.243Avg Price1Lot Size
Apellis Pharmaceuticals Key Stats
Apellis Pharmaceuticals Q3 2024 Earnings Date
Currency：USDNov 5, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 199.82M | 196.83M | -2.99M |
| Miss Est. | +81.00% | +78.29% | -1.50% |
| EPS | -0.31 | -0.46 | -0.15 |
| Miss Est. | +73.23% | +60.68% | -46.87% |
Analyst Rating
Nov 20, 2024
Apellis Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Apellis Pharmaceuticals Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
